Global Remote Patient Monitoring System Industry - Reportlinker Review

NEW YORK, Oct. 13, 2015 /PRNewswire/ -- This report analyzes the worldwide markets for Remote Patient Monitoring Systems in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 83 companies including many key and niche players such as -

Abbott Laboratories
Aerotel Medical Systems
AMD Global Telemedicine, Inc.
BIOTRONIK SE & Co. KG
Boston Scientific Corporation



Read the full report: http://www.reportlinker.com/p03283192-summary/view-report.html



I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1 Disclaimers.............. I-2 Data Interpretation & Reporting Level I-2 Quantitative Techniques & Analytics I-3 Product Definitions and Scope of Study I-3

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW.............. II-1 Remote Patient Monitoring (RPM) - A Transformation Model for Health Care Delivery..............II-1 Benefits for Patients, Physicians, & Payer II-2 Improved Patient Outcomes and Promoting Self-Care II-2 Resource Optimization and Savings - A Key Benefit II-2 Payer Benefits.............. II-3 Peek into Key Market Growth Drivers II-3 Focus on Healthcare Economics Grows as Healthcare Expenditures Rise Globally..............II-4 Table 1: Global Healthcare Spending (in US$ Trillion): 2013-2018 (includes corresponding Graph/Chart) II-5

Table 2: Healthcare Expenditure as a % of GDP Across Select Countries (includes corresponding Graph/Chart) II-6

Table 3: Elderly Healthcare Expenditure as a % of GDP (includes corresponding Graph/Chart) II-7 Aging Population Creates High Demand II-7 Table 4: Ageing (65+) Demographics as % of Total Population by Country (2000, 2011, 2020) (includes corresponding Graph/Chart).............. II-8 Chronic Disease Management Presents Huge Market Opportunity II-8 Table 5: World Market for Telehealth: Patient Distribution (in %) by Disease Condition (includes corresponding Graph/Chart).............. II-9

Table 6: Chronic Disease Management in Developed Countries (2014): Percentage Distribution of Patient Population by Chronic Disease Type in the US, Germany, and the UK (includes corresponding Graph/Chart) II-10 Readmission Penalty on Hospitals Provides Impetus to RPM II-10 Patient Non-Adherence to Prescribed Medication Promotes RPM Market.............. II-11 Table 7: Medication Adherence Rates in the US by Condition (2012) (includes corresponding Graph/Chart) II-11 Wearable Devices Help Boost RPM Adoption II-12 Venture Capitalists Keen to Fund RPM Technology Companies II-13 Table 8: Digital Health Venture Funding in the US (2011-2014) (includes corresponding Graph/Chart) II-14

Table 9: US Digital Health Venture Capital Funding by Category (in %): 2014 (includes corresponding Graph/Chart) II-14 Market Issues and Challenges..............II-15 High Cost of Remote Patient Monitoring Systems II-15 Lack of Reimbursement..............II-15 Patient Privacy Concerns..............II-15 Small Practices Challenged by Remote Monitoring Programs II-16 Security Issues of Medical Devices II-16 Competitor Landscape..............II-17 Table 10: Leading Players in the Global Remote Patient Monitoring Market: Percentage Breakdown of Market Share for Boston Scientific, GE Healthcare, Medtronic, Philips Healthcare, St. Jude Medical, and Others (includes corresponding Graph/Chart)..............II-17

2. MARKET TRENDS/ISSUES.............. II-18 Big Data Management Crucial for Effective RPM II-18 Internet of Things (IoT) - Crucial for Healthcare II-18 Cloud Computing: Enhancing RPM Adoption II-19 Partnerships Leverage on Mutual Expertise II-20 Will mHealth make Conventional RPM Obsolete? II-21 Wireless Consumer Devices Favored Over Telehealth II-22 Immobile Patients to Gain from Increased Uptake of Remote Monitoring Devices.............. II-22 CVD Continues to Grab Focus for Remote Monitoring II-23 Table 11: Global Annual Medical Cost of CVD in US$ Billion (2010-2030) (includes corresponding Graph/Chart) II-24

Table 12: Economic Burden of Cardiovascular Diseases between 2011 and 2015: Breakdown of Lost Output Value by Income Group (includes corresponding Graph/Chart) II-24 Remote Monitoring - New Standard of Care for Patients with CIEDs II-25 RPM to Reduce Costs Associated with Diabetes Management II-26 Table 13: Global Diabetes Mellitus Incidence among Ages 20-79 (2014E & 2035P): Prevalence (in Millions) and Percentage Share by Geographic Region (includes corresponding Graph/Chart).............. II-27

Table 14: Top Ten Countries Worldwide with the Highest Number of People (in the Age Group 20-79 Years) with DM (in Millions): 2014E & 2035P (includes corresponding Graph/Chart) II-28 Remote Monitoring for Neurodegenerative Disease Conditions II-28 Remote Monitoring of EEG & Treatment Adequacy II-29 Remote Monitoring Crucial for COPD and Asthma Management II-30 Rising Significance of Remote Blood Pressure Monitoring Benefits Market Adoption..............II-31 Table 15: Death Rates Due to Hypertension in Select Countries: 2012 (includes corresponding Graph/Chart) II-32

Table 16: Percentage Prevalence Rate of High Blood Pressure for Patients over 25 Years of Age by Region (1980 and 2013) - Africa, America, South East Asia, Europe, Eastern Mediterranean, and Western Pacific (includes corresponding Graph/Chart).............. II-33 Remote Patient Monitoring for Sleep Apnea II-33 Table 17: Percentage Prevalence of Sleep Apnea in Co-Morbidities by Type of Co-Morbidity (includes corresponding Graph/Chart)..............II-34

3. PRODUCT OVERVIEW.............. II-35 Introduction.............. II-35 Remote Patient Monitoring vs. Telehealth II-35 Current Monitoring Systems - A Systematic Review II-36 Remote Patient Monitoring - Architecture II-36 Benefits & Challenges of Remote Patient Monitoring Systems II-38

4. PRODUCT LAUNCHES/APPROVALS..............II-39 Omron Healthcare Launches BP Monitor II-39 ALR Technologies Seeks FDA Approval for New Health-e-Connect Feature.............. II-39 HTC Launches Monitoring Device HTC Grip II-39 Covidien Receives CE Marking for Nellcor System II-39 Intel-GE Launches Branded Health Harmony RPM Service II-39 Dexcom Receives FDA Approval for Dexcom SHARE Device II-39 Honeywell Unveils New Version of Genesis DM™ II-39 Honeywell Unveils Latest Version of LifeStream™ II-40 AMD Introduces Live Streaming Ultrasound Technology II-40 Vital Connect Receives FDA Clearance for HealthPatch™ Biosensor II-40 OSTAR Healthcare Launches Remote Patient Monitoring System in North America.............. II-40 Masimo's Radius-7 Wearable Monitor Receives CE Approval II-40 CardioMEMS System Receives FDA Approval II-40 ReliantHeart's Assist5® Ventricular Assist Device Receives CE Certification.............. II-40 HealthInterlink Receives 510(k) clearance for Beacon version 2.0 II-41 Verizon Receives FDA Clearance for Patient Engagement Tool II-41 Sensiotec Unveils Version 2.0 of Virtual Medical Assistant® II-41 InfoBionic Receives CE Certification for MoMe™ System II-41 Baxter Receives CE Marking for VIVIA Hemodialysis System II-41 Verizon Launches Remote Patient Monitoring Platform II-41 Preventice Receives CE Certification for BodyGuardian® Monitoring System..............II-41 Sorin's Smartview System Receives FDA Approval II-42 Healthx Launches Remote Patient Monitoring Platform II-42 Tactio Health Group Launches TactioDiabetes II-42 FDA Approves RP-VITA By iRobot Corp. & InTouch Health II-42

5. RECENT INDUSTRY ACTIVITY..............II-43 Integrity Applications Enters Distribution Agreements with Chinese Players.............. II-43 Roche and Qualcomm Enter Collaboration II-43 Honeywell Life Care and MobileHelp Expand Collaboration II-43 Honeywell HomMed Changes Name to Honeywell Life Care II-43 Welch Allyn Acquires HealthInterLink II-43 LabCorp and Envision Healthcare Invest in Vivify Health II-43 Vital Connect Enters Partnership with LifeWatch II-44 Aerocrine Collaborates with Microsoft II-44 Preventice and eCardio Diagnostics Enter Strategic Partnership II-44 Geneia Acquires Select Rights on ZephyrLIFE From Covidien II-44 Healthsense Raises Funding for Remote Patient Monitoring System II-44 Maxis Bhd and EWL Announce Partnership for Health Monitoring M2M Solution.............. II-44 eCardio Signs Agreement with Shandong Yocaly II-44 Medtronic Acquires Cardiocom..............II-45 CardioNet Enters Agreement with IMEC & Holst Centre II-45

6. FOCUS ON SELECT GLOBAL PLAYERS..............II-46 Abbott Laboratories (US)..............II-46 Aerotel Medical Systems (Israel) II-46 AMD Global Telemedicine, Inc. (US) II-47 BIOTRONIK SE & Co. KG (Germany)..............II-47 Boston Scientific Corporation (US) II-47 GE Healthcare Ltd. (UK)..............II-48 Honeywell Life Care Solutions (US) II-48 Intelesens Ltd. (UK)..............II-49 LifeWatch AG (Switzerland)..............II-49 Masimo Corporation (US)..............II-50 Medtronic Plc (Ireland)..............II-50 Mindray North America (US)..............II-51 Nihon Kohden Corporation (Japan) II-51 Omron Healthcare, Inc. (US)..............II-51 Philips Healthcare (Netherlands) II-52 Qualcomm Life, Inc. (US)..............II-52 St. Jude Medical Inc. (US)..............II-53 Welch Allyn, Inc. (US)..............II-53

7. GLOBAL MARKET PERSPECTIVE..............II-54 Table 18: World Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)..............II-54

Table 19: World Historic Review for Remote Patient Monitoring Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).............. II-55

Table 20: World 14-Year Perspective for Remote Patient Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart) II-56

III. MARKET

1. THE UNITED STATES.............. III-1 A.Market Analysis.............. III-1 Key Drivers to Remote Patient Monitoring Market III-1 Remote Monitoring Boosted by HRRP III-1 High Life Expectancy Presents Strong Need for RPM III-2 Table 21: Population of the US (2010, 2030 & 2050): Percentage Breakdown by Age Groups - Under 18, 18-64 years & 65+ years (includes corresponding Graph/Chart) III-2 US - The Leading Market for Remote Cardiac Monitoring III-2 Table 22: CVD in the US: Cardiovascular Disease Prevalence in Adults by Gender & Age Group (includes corresponding Graph/Chart).............. III-3

Table 23: CVD in the US: Cardiovascular Disease Incidence by Gender & Age Group (per 1,000 Adults) (includes corresponding Graph/Chart)..............III-3

Table 24: Leading Causes of CVD Fatalities in the US: Percentage Breakdown of Mortality for Coronary Heart Disease, HBP, Heart Failure, Stroke, and Others (includes corresponding Graph/Chart)..............III-3 Chronic Disease Management - Focus Area for Remote Monitoring III-4 Table 25: US Healthcare Spending (2006-2020) (in US$ Trillion) (includes corresponding Graph/Chart) III-5

Table 26: US Healthcare Market: Total Annual Expenditure in US$ Billion by Chronic Disorder/Disease (includes corresponding Graph/Chart)..............III-5 Diabetes Statistics in the US..............III-5 Table 27: Prevalence of Diabetes Mellitus in the US (2013 & 2035): Number of People with DM (in Thousands) in the 20-79 Age Group.............. III-6 Sleep Apnea in the US..............III-6 Rise in COPD Incidence Drives RPM Adoption III-7 Table 28: Chronic Obstructive Pulmonary Disorder (COPD) Incidence in US (2014): COPD Prevalence in Millions by Age Group (includes corresponding Graph/Chart) III-7 Reimbursement Scenario..............III-7 Remote Monitoring Systems with FDA 510(k) Clearance (2014): III-8 Product Launches..............III-8 Strategic Corporate Developments III-11 Key Players.............. III-13 B.Market Analytics..............III-18 Table 29: US Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)..............III-18

Table 30: US Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).............. III-18

2. CANADA.............. III-19 A.Market Analysis.............. III-19 Product Launch.............. III-19 B.Market Analytics..............III-20 Table 31: Canadian Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart) III-20

Table 32: Canadian Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).............. III-21

3. JAPAN.............. III-22 A.Market Analysis.............. III-22 Graying Population Spurs Growth of Patient Monitoring Equipment III-22 Table 33: Japanese Elderly (65+ Years) Population: 2000-2020 (includes corresponding Graph/Chart) III-22 Key Player - Nihon Kohden Corporation III-22 B.Market Analytics..............III-23 Table 34: Japanese Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart) III-23

Table 35: Japanese Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).............. III-24

4. EUROPE.............. III-25 A.Market Analysis.............. III-25 Prevalence of Diabetes in Europe: Market Opportunity for CGM Devices.............. III-25 B.Market Analytics..............III-26 Table 36: European Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)..............III-26

Table 37: European Historic Review for Remote Patient Monitoring Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).............. III-27

Table 38: European 14-Year Perspective for Remote Patient Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart) III-28

4a. FRANCE.............. III-29 Market Analysis.............. III-29 Table 39: French Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)..............III-29

Table 40: French Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).............. III-30

4b. GERMANY.............. III-31 A.Market Analysis.............. III-31 Key Player - Biotronik SE & Co. KG III-31 B.Market Analytics..............III-32 Table 41: German Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)..............III-32

Table 42: German Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).............. III-33

4c. ITALY.............. III-34 A.Market Analysis.............. III-34 Product Launch.............. III-34 B.Market Analytics..............III-34 Table 43: Italian Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)..............III-34

Table 44: Italian Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).............. III-35

4d. THE UNITED KINGDOM..............III-36 A.Market Analysis.............. III-36 Telecare and Elderly Population Requirements - An Overview III-36 Self-Monitoring Blood Glucose Meters Gain Popularity III-37 Product Approval..............III-37 Key Players.............. III-37 B.Market Analytics..............III-39 Table 45: UK Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)..............III-39

Table 46: UK Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).............. III-40

4e. SPAIN.............. III-41 Market Analysis.............. III-41 Table 47: Spanish Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)..............III-41

Table 48: Spanish Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).............. III-42

4f. RUSSIA.............. III-43 Market Analysis.............. III-43 Table 49: Russian Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)..............III-43

Table 50: Russian Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).............. III-44

4g. REST OF EUROPE.............. III-45 A.Market Analysis.............. III-45 Strategic Corporate Developments III-45 Key Players.............. III-45 B.Market Analytics..............III-47 Table 51: Rest of European Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart) III-47

Table 52: Rest of European Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)..............III-48

5. ASIA-PACIFIC.............. III-49 A.Market Analysis.............. III-49 Outlook.............. III-49 Improving Infrastructure Facilitates RPM Adoption III-49 Undiagnosed Diabetic Population Offers Potential for Remote Monitoring.............. III-49 B.Market Analytics..............III-50 Table 53: Asia-Pacific Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Region - China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart) III-50

Table 54: Asia-Pacific Historic Review for Remote Patient Monitoring Systems by Region - China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart) III-51

Table 55: Asia-Pacific 14-Year Perspective for Remote Patient Monitoring Systems by Region - Percentage Breakdown of Value Sales for China and Rest of Asia-Pacific Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).............. III-52

5a. CHINA.............. III-53 A.Market Analysis.............. III-53 Large Population Results in Quicker RPM Adoption III-53 Table 56: Healthcare Expenditure in China as a % of GDP (2006-2015) (includes corresponding Graph/Chart) III-54

Table 57: Percentage of Population Aged 65 and Above in China (2000-2020) (includes corresponding Graph/Chart) III-54

Table 58: Incidence of Chronic Diseases in China (2014) (includes corresponding Graph/Chart) III-54 China: An Untapped Goldmine for Blood Glucose Monitoring Devices.............. III-55 Strategic Corporate Development III-55 B.Market Analytics..............III-56 Table 59: Chinese Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)..............III-56

Table 60: Chinese Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).............. III-56

5b. REST OF ASIA-PACIFIC..............III-57 A.Market Analysis.............. III-57 India: Remote Patient Monitoring Gains Popularity III-57 Rising Diabetic Populace Spurs Growth in Remote Glucose Monitoring Devices..............III-57 Strategic Corporate Development III-58 B.Market Analytics..............III-59 Table 61: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart) III-59

Table 62: Rest of Asia-Pacific Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)..............III-60

6. LATIN AMERICA.............. III-61 Market Analysis.............. III-61 Table 63: Latin American Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Region - Brazil and Rest of Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart) III-61

Table 64: Latin American Historic Review for Remote Patient Monitoring Systems by Region - Brazil and Rest of Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)..............III-62

Table 65: Latin American 14-Year Perspective for Remote Patient Monitoring Systems by Region - Percentage Breakdown of Value Sales for Brazil and Rest of Latin American Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart).............. III-63

6a. BRAZIL.............. III-64 Market Analysis.............. III-64 Table 66: Brazilian Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart) III-64

Table 67: Brazilian Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).............. III-65

6b. REST OF LATIN AMERICA..............III-66 Market Analysis.............. III-66 Table 68: Rest of Latin American Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart) III-66

Table 69: Rest of Latin American Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)..............III-67

7. REST OF WORLD.............. III-68 A.Market Analysis.............. III-68 Key Player - Aerotel Medical Systems (Israel) III-68 B.Market Analytics..............III-69 Table 70: Rest of World Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart) III-69

Table 71: Rest of World Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart).............. III-70

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 83 (including Divisions/Subsidiaries - 85)

The United States (55) Canada (6) Japan (1) Europe (16) - Germany (3) - The United Kingdom (4) - Italy (1) - Rest of Europe (8) Asia-Pacific (Excluding Japan) (4) Middle East (3)
Read the full report: http://www.reportlinker.com/p03283192-summary/view-report.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker reviews, finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

http://www.reportlinker.com


__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

Related Links

http://www.reportlinker.com